Ordering
Available Variants5 mg
CHA.97505-5mg
Price
€143.20
Available – Dispatch in 14 days
25 mg
CHA.97505-25mg
Price
€572.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.97505-5mg | €143.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.97505-25mg | €572.00 |
≥98% (HPLC), nuclear receptor REV-ERB agonist, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C23H31ClN4O3S |
|---|---|
| CAS Number | 1379686-29-9 |
| Molecular Weight | 479.04 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319 |
| pcodes | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
SR9011, also known by its CAS number 2070014-94-5, is a synthetic compound that has been identified as a potent agonist of the Rev-ErbA alpha protein. This nuclear receptor plays a crucial role in regulating various physiological processes, including lipid and glucose metabolism, as well as circadian rhythm. Research has demonstrated that SR9011 can modulate the activity of Rev-ErbA alpha, leading to increased mitochondrial biogenesis and enhanced fatty acid oxidation. Additionally, SR9011 has been shown to influence the expression of genes involved in metabolic pathways, resulting in improved metabolic function and increased energy expenditure. The compounds potential therapeutic applications are being explored, with possible uses in the treatment of metabolic disorders and other diseases associated with disrupted circadian rhythms and impaired energy metabolism. Further studies are necessary to fully elucidate the effects and mechanisms of SR9011.
